期刊文献+

Exendin-4对2型糖尿病大鼠肾组织MMP-9与TIMP-1表达的影响

Effects of Exendin-4 on Expression of Matrix Metalloproteinase-9 and Tissue Inhibitor of Metalloproteinase-1 in Renal Tissue of Type 2 Diabetic Rats
暂未订购
导出
摘要 目的观察Exendin-4对2型糖尿病大鼠肾组织基质金属蛋白酶9(MMP-9)、金属蛋白酶组织抑制物1(TIMP-1)表达的影响。方法建立2型糖尿病大鼠模型后,分为糖尿病组,exendin-4低、中、高剂量组。给药6周后,采用免疫组织化学方法检测各组大鼠肾组织中MMP-9、TIMP-1的蛋白表达。结果糖尿病组MMP-9、TIMP-1的表达较正常对照组明显增强(P<0.01);exendin-4各组较糖尿病组MMP-9、TIMP-1表达减弱(P均<0.01)。结论 Exendin-4对2型糖尿病大鼠有一定的肾脏保护作用,其机制可能部分是通过下调2型糖尿病大鼠肾组织MMP-9和TIMP-1的表达来实现的。 Objective To observe the effects of exendin-4 on the expression of matrix metalloproteinase-9(MMP-9) and tissue inhibitor of metalloproteinase-1 (TIMP-1) in the renal tissue of type 2 diabetic rats. Methods The diabetic rats were divided into 4 groups: diabetes mellitus group(DM group), low dose of exendin-4 group(EL group), middle dose of exendin-4 group(EM group), high dose of exendin-4 group(EH group). After 6 weeks, the expression of MMP-9 and TIMP-1 in renal tissue was measured by immunohistochemistry. Results The expression of MMP-9 and TIMP-1 in DM group was higher than that in NC group(P〈0 .01), while the expression of MMP-9 and TIMP-1 in all doses of exendin-4 groups was lower than that in DM group(P〈0 .01).Conclusion Exendin-4 has some renoprotective effect on type 2 diabetic rats, partly through down-regulating the expression of MMP-9 and TIMP-1.
作者 焦亮 耿艳
出处 《中国医药指南》 2010年第31期22-23,共2页 Guide of China Medicine
关键词 EXENDIN-4 2型糖尿病 糖尿病肾病 基质金属蛋白酶9 金属蛋白酶组织抑制物1 Exendin-4 Type 2 diabetes mellitus Diabetic nephropathy Matrix metalloproteinase-9 Tissue inhibitor of metalloproteinase-1
  • 相关文献

参考文献8

  • 1Goke R,Fehmann HC,Linn T,et al.Exendin-4 is a high potency agonist and truncated exendin-(9-39)-amide an antagonist at the glucagnn-like peptide 1-(7-36)-amide receptor of insulin-secreting -cells[J].J Biol Chem,1993,268(26):19650-19655.
  • 2Gutzwiller JP,Tschopp S,Bock A,et al.Glucagon-like peptide 1 induces natriuresis in healthy subjects and in insulin-resistant obese men[J].J Clin Endocrinol Metab,2004,89(6):3055-3061.
  • 3Park CW,Kim HW,Ko SH,et al.Long-term treatment of glucagonlike peptide-1 analog exendin-4 ameliorates diabetic nephropathy through improving metabolic anomalies in db/db mice[J].J Am Soc Nephrol,2007,18(4):1227-1238.
  • 4Schaefer L,Han X,August C,et al.Differential regulation of glomerular gelatinase B(MMP-9) and tissue inhibitor of metalloproteinase-1 (TIMP-1) in obese Zucker rats[J].Diabetologia,1997,40(9):1035-1043.
  • 5Tashiro K,Koyanagi I,Ohara I,et al.Levels of urinary matrix metalloproteinase-9 (MMP-9) and renal injuries in patients with type 2 diabetic nephropathy[J].J Clin Lab Anal,2004,18(3):206-210.
  • 6Nielsen LL,Young AA,Parkes DG.Pharmacology of exenatide (synthetic exendin-4):A potential therapeutic for improved glycemic control of type 2 diabetes[J].Regul Pept,2004,117(2):77-88.
  • 7Kolterman OG,Buse JB,Fineman MS,et al.Synthetic exendin-4 (Exenatide) Significantly reduces postprandial and fasting plasma glucose in subjects with type 2 diabetes[J].J Clin Endocrinol Metab,2003,88(7):3082-3089.
  • 8Brubaker PL,Drucker DJ.Structure-function of the glucagon receptor family of G protein-coupled receptors:the glucagon,GIP,GLP-1,and GLP-2 receptors[J].Receptors Channels,2002,8(3/4):179-188.

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部